Abstract |
This consensus document is proposed to clinicians to provide the whole spectrum of deep vein thrombosis management as an update to the 2017 consensus document. New data guiding clinicians in indicating extended anticoagulation, management of patients with cancer, and prevention and management of post-thrombotic syndrome are presented. More data on benefit and safety of non- vitamin K antagonists oral anticoagulants are highlighted, along with the arrival of new antidotes for severe bleeding management.
|
Authors | Lucia Mazzolai, Walter Ageno, Adriano Alatri, Rupert Bauersachs, Cecilia Becattini, Marianne Brodmann, Joseph Emmerich, Stavros Konstantinides, Guy Meyer, Saskia Middeldorp, Manuel Monreal, Marc Righini, Victor Aboyans |
Journal | European journal of preventive cardiology
(Eur J Prev Cardiol)
Vol. 29
Issue 8
Pg. 1248-1263
(05 27 2022)
ISSN: 2047-4881 [Electronic] England |
PMID | 34254133
(Publication Type: Journal Article)
|
Copyright | © The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. |
Chemical References |
|
Topics |
- Anticoagulants
(adverse effects)
- Aorta
- Consensus
- Humans
- Peripheral Vascular Diseases
- Pulmonary Circulation
- Thrombolytic Therapy
(adverse effects)
- Venous Thrombosis
(diagnosis, drug therapy)
- Ventricular Function, Right
|